Zyvex Continues to Exceed Sales Expectations

Jan 25, 2005, 00:00 ET from Zyvex Corporation

    RICHARDSON, Texas, Jan. 25 /PRNewswire/ -- Zyvex today announced financial
 results for its fiscal 2004 fourth quarter.  The Texas company continues its
 business gains with nine consecutive quarters of sales growth and expansion of
 its global sales reach.
     Total revenue for the fourth quarter was $4.0 million, which was a
 55 percent increase over the same period in 2003.
     The total revenue for 2004 was $8.6 million, which represented a
 102 percent increase over 2003.  International sales, new to the company
 during 2004, accounted for 10 percent of the year's revenue.
     "I continue to be extremely pleased with the financial and operational
 performance of the company during the last 24 months, particularly during
 2004," stated Zyvex's CFO Timothy M. Gilmore.  "Our introduction of the
 extremely popular IC Nanoprober(TM) during the fourth quarter drove these
 positive results for the quarter and year.  While we are gratified by the
 success of this product, our 2005 plans do not anticipate this initial buy-in
 to continue at the same level."
     Zyvex shipped 29 of their NanoWorks(TM) Nanomanipulation Systems during
 the year, representing a 400 + percent increase in units over the year-ago
 period.  During the year, the Company introduced eleven new products -- nine
 of which were launched during the fourth quarter.  Net loss for the year was
 reduced by 42 percent over 2003.
     "Zyvex is enabling new applications in the semiconductor industry with our
 IC Probing offerings," said Zyvex President Thomas A. Cellucci, PhD, MBA.
 "The response to our systems was so successful that we ended up with a
 significant backlog of orders in Q3 added to the highest number of orders for
 a quarter in Q4.  We anticipate that 2005's revenue will exceed $10 million."
     Founded in 1997, Zyvex reported its first revenues in 2001, grossing only
 $150,000.  Company revenues grew to $1.2 million in 2002, $4.3 million in
 2003, and $8.6 million in 2004.  Gilmore anticipates that the company will
 achieve cash-flow break-even by Q1 2006, and become bottom-line profitable by
 the end of 2006.
     The company has customers in the Aerospace/Defense, Healthcare/Medical,
 and Electronics/Semiconductor industries.  2004 saw a 225 percent increase in
 customers, and a 75 percent increase in partnerships and alliances.
     Zyvex also has numerous key alliances with industry leaders, including
 Easton Sports, FEI Company, Frost & Sullivan, MANCEF, MIT's Institute for
 Soldier Nanotechnologies, Texas Instruments and many others.
     Zyvex has worldwide sales representation in China, France, Germany, Italy,
 Japan, Korea, Malaysia, Poland, Singapore, Switzerland, Taiwan, Thailand, the
 United Kingdom, and Vietnam through alliances with Keithley Instruments, Inc.,
 Caltron, Pte., and L.O.T.-Oriel.
     About the Company
     Zyvex Corporation, based in Richardson, Texas, is the first molecular
 nanotechnology company.  Zyvex's vision is to be the leading worldwide
 supplier of tools, products, and services that enable adaptable, affordable,
 and molecularly precise manufacturing.  Zyvex commercializes nanotechnology to
 address real-world applications with high growth potential.  Zyvex carries its
 scientific breakthroughs into key commercial applications in the area of
 materials, tools, and structures.

SOURCE Zyvex Corporation